A randomized study on the effects of intramuscular injections with urinary gonadotrophins (Humegon or Pergonal) on pain, local redness and fever in infertile women opting for in-vitro fertilization

Human Reproduction

Volumn 12, Issue 7, 1997, Pages 1427-1429

  Verhoeff, A ^a   Schmoutziguer, A P E ^b   Doesburg, W H ^c   Gan, R A ^d   Geurts, T B P ^d  

^a Zuiderziekenhuis   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d NV ORGANON   (Netherlands)

Author keywords

Gonadotrophin; Injection; Intramuscular; IVF; Pain

Indexed keywords

HUMAN MENOPAUSAL GONADOTROPIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ERYTHEMA; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FEVER; HUMAN; INJECTION PAIN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT;

EID: 0030854306     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/12.7.1427     Document Type: Article

References (11)

1. Biffoni, M., Battaglia, A., Borelli, F. et al. (1994) Allergenic potential of gonadotrophic preparations in experimental animals: relevance of purity. Hum. Reprod., 9, 1845-1848.
2. Dore, P.C., Rice, C. and Killick, S. (1994) Human gonadotrophin preparations; may cause allergic reaction. Br. Med. J., 308, 1509.
3. Editorial (1992) New gonadotropins for old? Lancet, 340, 1442-1443.
4. Gilder, R., Hammarberg, K., Brookes, C. et al. (1993) How painful are HMG injections? Abstract presented at the Annual Meeting of the Fertility Society of Australia, 1993.
5. Giudice, E., Crisci, C., Eshkol, A. and Papoian, R. (1994) Composition of commercial gonadotrophin preparations extracted from human postmenopausal urine: characterization of non-gonadotrophin proteins. Hum. Reprod., 9, 2291-2299.
6. Harika, G., Gabriel, R., Quereux, C. et al. (1994) Hypersensitization to human menopausal gonadotropins with anaphylactic shock syndrome during a fifth in vitro fertilization cycle. J. Assist. Reprod. Genet., 11, 51-52.
7. Li, T.C. and Hindle, J.E. (1993) Adverse local reaction to intramuscular injections of urinary-derived gonadotropins. Hum. Reprod., 8, 1835-1836.
8. Odink, J., Zuiderwijk, P.B.M., Schoen, E.D. and Gan, R.A. (1995) A prospective, double-blind, split-subject study on local skin reactions after administration of human menopausal gonadotrophin preparations to healthy female volunteers. Hum. Reprod., 10, 1045-1047.
9. Out, H.J., Reimitz, P.E. and Coelingh Bennink, J.HT. (1997) A prospective. randomized, study to assess the tolerance and efficacy of intramuscular and subcutaneous administration of recombinant follicle-stimulating hormone (Puregon). Fertil. Steril., 67, 278-283.
10. Redfearn, A., Hughes, E.G., O'Connor, M. and Dolovich, J. (1995) Delayed-type hypersensitivity to human gonadotropin: case report. Fertil. Steril., 64, 855-856.
11. Stokman, P.G.W., de Leeuw, R., van den Wijngaard, H.A.G.W. et al. (1993) Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations. Fertil. Steril., 60, 175-178.